Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Torben Noerup Nielsen who wrote (15728)	2/24/1998 8:50:00 AM
From: Henry Niman	of 32384

Joe Kernan just gave his take on the failed merger. Indicated that SBH would be down about 10% and GLX closed at $62 but was indicated to open at $53.50. He thought that deal reflected poorly on sector. Affected many lives and fell apart because of personalities. Noted that SBH had failed twice now, raising questions in investor's minds. He also indicated that he was disappointed. Thought that genomics and screening of large libraries complimented each other, and he was excited about a $3 R&D budget. Followup CNBC report indicates that big deals made be harder to do than initially expected and investors should look at pharmas that already had good pipelines. One analysts cited LLY and WLA as examples.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next